Participants 82 110 3
metastatic colorectal cancer
Participants 282 494 5
patients with epidermal growth factor receptor-expressing, metastatic colorectal carcinoma with disease progression on or following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens
Participants 817 859 5
patients with metastatic colorectal cancer
Participants 993 1023 4
Patients receiving panitumumab
Participants 1180 1233 4
patients receiving bevacizumab and chemotherapy alone
